>
pdufa.bio

rigosertib

Updated ยทnext FDA decision on the calendar

rigosertib is a Traws Pharma, Inc. program. Its next catalyst is a Readout in Dec 2026. Every date links its source.

TRAW catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Traws Pharma, Inc. (TRAW). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Dec 2026TRAW

Questions

When is rigosertib's next FDA decision or readout?

The next tracked catalyst for rigosertib is a Readout in Dec 2026.

What happened at rigosertib's most recent FDA decision?

No FDA decision for rigosertib is in our archive yet.

Who makes rigosertib?

Traws Pharma, Inc. (TRAW).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.